InvestSMART

Ansell Limited (ASX:ANN)

ALERT: Price-sensitive ASX Announcement for ANN
Current share price for ANN : $45.560 10.66 (30.54%)+
Announcement
Release
24 Aug 2026 7:34AM
Price at Release
$34.900
Full Release
download
Summary
Ansell Limited's FY26 full year results show strong sales and earnings growth, achieving a 6.8% increase in sales and a 14.1% increase in Adjusted EBIT. The company effectively navigated dynamic market conditions, including the US tariffs and the Middle East crisis, through strategic sourcing and pricing actions. Ansell's healthcare segment experienced double-digit earnings growth, with improvements in cleanroom solutions and surgical synthetics. The balance sheet remained robust with a Baa2 investment grade rating, supported by significant liquidity and strong cash flow, which funded share buybacks and debt reduction. Strategic priorities included focusing on commercial excellence and operational improvements to drive future growth.
Key Points
  • Strong sales and earnings growth in FY26 with 6.8% sales increase.
  • Adjusted EBIT increased by 14.1%, reaching 321.9 million USD.
  • Effective offset of US tariffs and Middle East crisis costs through sourcing and pricing strategies.
  • Healthcare segment achieved double-digit earnings growth.
  • Significant liquidity and robust balance sheet with Baa2 investment grade rating.
  • Cash conversion improved to 113%, supporting debt reduction and share buybacks.
  • Strategic focus on commercial excellence and operational improvements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.